1,182
Views
2
CrossRef citations to date
0
Altmetric
Research Paper

Somatostatin attenuates intestinal epithelial barrier injury during acute intestinal ischemia–reperfusion through Tollip/Myeloiddifferentiationfactor 88/Nuclear factor kappa-B signaling

, , , , &
Pages 5005-5020 | Received 26 Nov 2021, Accepted 01 Feb 2022, Published online: 14 Feb 2022

References

  • Gonzalez LM, Moeser AJ, Blikslager AT. Animal models of ischemia-reperfusion-induced intestinal injury: progress and promise for translational research. Am J Physiol Gastrointest Liver Physiol. 2015;308(2):G63.
  • Huang Y, Rabb H, Womer KL. Ischemia-reperfusion and immediate T cell responses. Cell Immunol. 2007;248(1):4–11.
  • Hassoun HT, Kone BC, Mercer DW, et al. Post-injury multiple organ failure: the role of the gut. Shock. 2001;15(1):1–10.
  • Anderson JM, Van Itallie CM. Tight junctions and the molecular basis for regulation of paracellular permeability. A J Physiol. 1995;269(4 Pt 1):G467–475.
  • Rose E, Odle J, Blikslager A, et al. Probiotics, prebiotics and epithelial tight junctions: a promising approach to modulate intestinal barrier function. Int J Mol Sci. 2021;22(13):6729.
  • Paradis T, Bègue H, Basmaciyan L, et al. Tight junctions as a key for pathogens invasion in intestinal epithelial cells. Int J Mol Sci. 2021;22(5):2506.
  • Guo S, Al-Sadi R, Said HM, et al. Lipopolysaccharide causes an increase in intestinal tight junction permeability in vitro and in vivo by inducing enterocyte membrane expression and localization of TLR-4 and CD14. Am J Pathol. 2013;182(2):375–387.
  • Capaldo CT, Nusrat A. Cytokine regulation of tight junctions. Biochim Biophys Acta. 2009;1788(4):864–871.
  • Lin Y, Jamison S, Lin W. Interferon-γ activates nuclear factor-κ B in oligodendrocytes through a process mediated by the unfolded protein response. PLoS One. 2012;7(5):e36408.
  • Shibahara T, Miyazaki K, Sato D, et al. Alteration of intestinal epithelial function by intraepithelial lymphocyte homing. J Gastroenterol. 2005;40(9):878–886.
  • Schulzke JD, Ploeger S, Amasheh M, et al. Epithelial tight junctions in intestinal inflammation. Ann N Y Acad Sci. 2009;1165(1):294–300.
  • Boivin MA, Roy PK, Bradley A, et al. Mechanism of interferon-gamma-induced increase in T84 intestinal epithelial tight junction. J Interferon Cytokine Res. 2009;29(1):45–54.
  • Häcker H, Karin M. Regulation and function of IKK and IKK-related kinases. Sci STKE. 2006;2006(357):re13.
  • Fazal F, Gu L, Ihnatovych I, et al. Inhibiting myosin light chain kinase induces apoptosis in vitro and in vivo. Mol Cell Biol. 2005;25(14):6259–6266.
  • Han X, Lee A, Huang S, et al. Lactobacillus rhamnosus GG prevents epithelial barrier dysfunction induced by interferon-gamma and fecal supernatants from irritable bowel syndrome patients in human intestinal enteroids and colonoids. Gut Microbes. 2019;10(1):59–76.
  • Min C, Pei W, Chunhong S, et al. Amelioration of IFN-γ and TNF-α-induced intestinal epithelial barrier dysfunction by berberine via suppression of MLCK-MLC phosphorylation signaling pathway. PLoS ONE. 2013;8(5):e61944.
  • Ma TY, Boivin MA, Ye D, et al. Mechanism of TNF-{alpha} modulation of Caco-2 intestinal epithelial tight junction barrier: role of myosin light-chain kinase protein expression. Am J Physiol Gastrointest Liver Physiol. 2005;288(3):G422–430.
  • Shen L, Black ED, Witkowski ED, et al. Myosin light chain phosphorylation regulates barrier function by remodeling tight junction structure. J Cell Sci. 2006;119(Pt 10):2095–2106.
  • Liu L, Tan Q, Hu B, et al. Somatostatin inhibits the production of interferon-gamma by intestinal epithelial cells during intestinal ischemia-reperfusion in macaques. Dig Dis Sci. 2014;59(10):2423–2432.
  • Wu H, Liu L, Tan Q, et al. Somatostatin limits intestinal ischemia-reperfusion injury in macaques via suppression of TLR4-NF-kappaB cytokine pathway. J Gastrointest Surg. 2009;13(5):983–993.
  • Zaros Y, Kao J, and Merchant Y, et al. Inflamation and Cancer III. Somatostatin and the innate immune system. Am J Physiol Gastrointestinal Liver Physiol. 2004;286(5):G698-701.
  • Gonzalez-Rey E, Chorny A, Delgado M. Regulation of immune tolerance by anti-inflammatory neuropeptides. Nat Rev Immunol. 2007;7(1):52–63.
  • Ameri P, Ferone D. Diffuse endocrine system, neuroendocrine tumors and immunity: what’s new? Neuroendocrinology. 2012;95(4):267–276.
  • Arumugam T, Okun E, Tang S, et al. Toll-like receptors in ischemia-reperfusion injury. Shock. 2009;32(1):4–16.
  • Michelsen KS, Arditi M. Toll-like receptors and innate immunity in gut homeostasis and pathology. Curr Opin Hematol. 2007;14(1):48–54.
  • Fukata M, Abreu MT. TLR4 signalling in the intestine in health and disease. Biochem Soc Trans. 2007;35(Pt 6):1473–1478.
  • Gewirtz AT. Intestinal epithelial toll-like receptors: to protect. And serve?. Curr Pharm Des. 2003;9(1):1–5.
  • Kawai T, Akira S. Signaling to NF-kappaB by Toll-like receptors. Trends Mol Med. 2007;13(11):460–469.
  • Kawai T, Akira S. TLR signaling. Semin Immunol. 2007;19(1):24–32.
  • Li X, Goobie GC, and Gregory A, et al. TOLL-interacting protein in pulmonary diseases: abiding by the Goldilocks principle. Am J Respir Cell Mol Biol. 2020;64(5):536-546.
  • Li X, Goobie GC, Zhang Y. Toll-interacting protein impacts on inflammation, autophagy, and vacuole trafficking in human disease. J Mol Med. 2021;99(6):1–11.
  • Wu C, Deng H, Li D, et al. Ctenopharyngodon idella Tollip regulates MyD88-induced NF-κB activation. Dev Comp Immunol. 2021;123:104162.
  • He S, Guo Y, Zhao J, et al. Ferulic acid ameliorates lipopolysaccharide-induced barrier dysfunction via MicroRNA-200c-3p-Mediated activation of PI3K/AKT pathway in Caco-2 cells. Front Pharmacol. 2020;11:376.
  • Gutiérrez-Sánchez G, García-Alonso I, Gutiérrez Sáenz de Santa María J, et al. Antioxidant-based therapy reduces early-stage intestinal ischemia-reperfusion injury in rats. Antioxidants (Basel). 2021;10(6). DOI:10.3390/antiox10060853
  • Li N, Pang B, Li J, et al. Mechanisms for Lactobacillus rhamnosus treatment of intestinal infection by drug-resistant Escherichia coli. Food Funct. 2020;11(5):4428–4445.
  • Zeng L, Tan J, Xue M, et al. An engineering probiotic producing defensin-5 ameliorating dextran sodium sulfate-induced mice colitis via Inhibiting NF-kB pathway. J Transl Med. 2020;18(1):107.
  • Mura M, Andrade CF, Han B, et al. Intestinal ischemia-reperfusion-induced acute lung injury and oncotic cell death in multiple organs. Shock. 2007;28(2):227–238.
  • Daudel F, Freise H, Westphal M, et al. Continuous thoracic epidural anesthesia improves gut mucosal microcirculation in rats with sepsis. Shock. 2007;28(5):610–614.
  • Arumugam TV, Shiels IA, Woodruff TM, et al. The role of the complement system in ischemia-reperfusion injury. Shock. 2004;21(5):401–409.
  • Stefanutti G, Pierro A, Vinardi S, et al. Moderate hypothermia protects against systemic oxidative stress in a rat model of intestinal ischemia and reperfusion injury. Shock. 2005;24(2):159–164.
  • Gu L, Li N, Gong J, et al. Berberine ameliorates intestinal epithelial tight-junction damage and down-regulates myosin light chain kinase pathways in a mouse model of endotoxinemia. J Infect Dis. 2011;203(11):1602–1612.
  • Ma TY, Iwamoto GK, Hoa NT, et al. TNF-alpha-induced increase in intestinal epithelial tight junction permeability requires NF-kappa B activation. Am J Physiol Gastrointest Liver Physiol. 2004;286(3):G367–376.
  • Yang S, Yu M, Sun L, et al. Interferon-γ-induced intestinal epithelial barrier dysfunction by NF-κB/HIF-1α pathway. J Interferon Cytokine Res. 2014;34(3):195–203.
  • Chowers Y, Cahalon L, Lahav M, et al. Somatostatin through its specific receptor inhibits spontaneous and TNF-alpha- and bacteria-induced IL-8 and IL-1 beta secretion from intestinal epithelial cells. J Immunol. 2000;165(6):2955–2961.
  • Zhu TJ, Dong GR, Huang GQ, et al. [The effects of somatostatin on serum interleukin-6 and tumor necrosis factor-alpha in lipopolysaccharide-induced septic shock: experiment with rats]. Zhonghua Yi Xue Za Zhi. 2007;87(5):345–347.
  • Aprahamian CJ, Lorenz RG, Harmon CM, et al. Toll-like receptor 2 is protective of ischemia-reperfusion-mediated small-bowel injury in a murine model. Pediatr Crit Care Med. 2008;9(1):105–109.
  • Gibson DL, Ma C, Rosenberger CM, et al. Toll-like receptor 2 plays a critical role in maintaining mucosal integrity during Citrobacter rodentium-induced colitis. Cell Microbiol. 2008;10(2):388–403.
  • Kawai T, Akira S. The roles of TLRs, RLRs and NLRs in pathogen recognition. Int Immunol. 2009;21(4):317–337.
  • Watanabe T, Tanigawa T, Kobata A, et al. Toll-like receptor 2 mediates ischemia-reperfusion injury of the small intestine in adult mice. PLoS One. 2014;9(10):e110441.